Literature DB >> 21113188

Large pericardial effusion as a complication in adults undergoing SCT.

M Norkin1, V Ratanatharathorn, L Ayash, M H Abidi, Z Al-Kadhimi, L G Lum, J P Uberti.   

Abstract

Large pericardial effusion (LPE) leading to cardiac tamponade is a rare complication described in patients undergoing SCT. This complication is considered to be a manifestation of chronic GVHD; however its pathophysiology is poorly understood. Currently, there are no published data systematically describing the incidence, clinical characteristics and outcomes of LPEs in adult stem cell transplant recipients. We retrospectively evaluated 858 adult patients (512 autologous, 148 related and 198 unrelated donor) who underwent hematopoietic stem cell and BM transplants at our institution from 2005 to 2008 for the development of post transplant LPE. Seven patients (0.8%) were found to have LPEs and all these patients had undergone unrelated allografts. The median day of diagnosis post transplant was 229 (range 42-525). None of these patients had active manifestations of GVHD other than serositis at the time of LPE detection. Pericardial window (PW) was successfully placed in all patients who developed cardiac tamponade and most patients with LPE were effectively treated by increasing immunosuppression. We conclude that LPE is a rare late complication after allogeneic transplant in adults and in our study developed only after unrelated transplant. PW can be safely performed in these patients and LPEs can be successfully treated with intensification of systemic immunosupression.

Entities:  

Mesh:

Year:  2010        PMID: 21113188      PMCID: PMC3809105          DOI: 10.1038/bmt.2010.297

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

1.  Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia.

Authors:  E Angelucci; E Mariotti; G Lucarelli; D Baronciani; P Cesaroni; S M Durazzi; M Galimberti; C Giardini; P Muretto; P Polchi
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

2.  A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.

Authors:  Manuela Cereda; Giuseppe Trocino; Enrico Maria Pogliani; Riccardo Schiavina
Journal:  Ital Heart J       Date:  2003-01

3.  Pericardial effusion following conditioning for bone marrow transplantation in acute leukaemia.

Authors:  P A Veys; R McAvinchey; M T Rothman; G H Mair; A C Newland
Journal:  Bone Marrow Transplant       Date:  1987-08       Impact factor: 5.483

4.  Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia.

Authors:  J Cavet; A Lennard; A Gascoigne; R D Finney; H H Lucraft; C Richardson; P R Taylor; S J Proctor; G H Jackson
Journal:  Bone Marrow Transplant       Date:  2000-03       Impact factor: 5.483

Review 5.  Chronic graft-versus-host disease: clinical manifestation and therapy.

Authors:  V Ratanatharathorn; L Ayash; H M Lazarus; J Fu; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2001-07       Impact factor: 5.483

6.  Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997.

Authors:  T Murdych; D J Weisdorf
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

7.  Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion.

Authors:  L Silberstein; A Davies; S Kelsey; J Foran; C Murrell; D D'Cruz; S Vinnicombe; A Norton; J Cavenagh
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

8.  Localization of pericardial effusion with wide angle phased array echocardiography.

Authors:  R P Martin; H Rakowski; J French; R L Popp
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

9.  BCNU toxicity presenting with a large pericardial and pleural effusion.

Authors:  Ganapathy S Krishnan; Vijay Chaudhary; Anas Al-Janadi; Jeyanthi Ramanarayanan; Karl J D'Silva
Journal:  Ann Transplant       Date:  2008       Impact factor: 1.530

10.  Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient.

Authors:  T J Walsh; B H Bulkley
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

View more
  11 in total

1.  Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant.

Authors:  X Chen; Q Zou; J Yin; C Wang; J Xu; J Wei; Y Zhang
Journal:  Bone Marrow Transplant       Date:  2015-10-19       Impact factor: 5.483

2.  Acute pericarditis before engraftment in hematopoietic stem cell transplantation.

Authors:  A Shinohara; A Honda; A Nukina; K Takaoka; A Tsukamoto; S Hangai; Y Kogure; T Kobayashi; S Yamazaki; K Ueda; F Nakamura; Y Nannya; M Kurokawa
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

3.  Pericardial effusion as a complication of chronic graft versus host disease.

Authors:  Keaton Nasser; Kshipra Joshi; Ella Starobinska
Journal:  BMJ Case Rep       Date:  2018-12-14

4.  Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy.

Authors:  D Lerner; C Dandoy; R Hirsch; B Laskin; S M Davies; S Jodele
Journal:  Bone Marrow Transplant       Date:  2014-03-17       Impact factor: 5.483

5.  Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.

Authors:  Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Joseph P Uberti
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

6.  Chronic GvHD-associated serositis and pericarditis.

Authors:  J T Leonard; L F Newell; G Meyers; B Hayes-Lattin; J Gajewski; S Heitner; S Nonas; B Allen; A Stentz; R Frires; R T Maziarz; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

7.  The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults.

Authors:  S J Rotz; T D Ryan; S Jodele; J L Jefferies; A Lane; A Pate; R Hirsch; J Hlavaty; A E Levesque; M D Taylor; M Cash; K C Myers; J A El-Bietar; S M Davies; C E Dandoy
Journal:  Bone Marrow Transplant       Date:  2017-04-10       Impact factor: 5.483

Review 8.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

Review 9.  A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors:  Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal:  Blood Rev       Date:  2014-11-28       Impact factor: 8.250

10.  Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation.

Authors:  Tang-Her Jaing; Shih-Hsiang Chen; Yu-Chuan Wen; Tsung-Yen Chang; Dai-Yun Tsai; Hung-Tao Chung; Pei-Kwei Tsay
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.